TG Therapeutics logo
TG Therapeutics TGTX
$ 23.83 2.14%

Quarterly report 2024-Q2
added 08-09-2024

report update icon

TG Therapeutics Balance Sheet 2011-2024 | TGTX

Annual Balance Sheet TG Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

8.63 M -29.6 M -231 M -544 M -55.9 M -41.9 M -56.6 M -25 M -54.8 M -55.4 M -39.7 M -13.3 M -4.86 M

Long Term Debt

100 M 71.1 M 66.8 M 7.72 M 29 M - - - - - 64.5 K 2.48 M 4.01 M

Long Term Debt Current

1.45 M 1.58 M 1.44 M 1.67 M 1.62 M - - - - - - - -

Total Non Current Liabilities

- - - - 40 M 20.7 M 2.43 M 2.04 M 1.37 M 1.52 M 1.74 M 4.31 M 4.66 M

Total Current Liabilities

53.7 M 53.2 M 65.4 M 87.6 M 84.4 M 38.9 M 28 M 16.9 M 10.5 M 5.12 M 6.32 M 2.22 M 1.61 M

Total Liabilities

169 M 135 M 142 M 106 M 124 M 59.6 M 30.4 M 18.9 M 11.9 M 6.65 M 8.06 M 6.52 M 6.27 M

Deferred Revenue

- - - - - 152 K 152 K 152 K 152 K 152 K 152 K 152 K -

Retained Earnings

-1.51 B -1.53 B -1.33 B -981 M -701 M -528 M -355 M -236 M -158 M -95.2 M -39.4 M -18.9 M -853 K

Total Assets

330 M 194 M 380 M 626 M 163 M 83.6 M 97.4 M 54.8 M 113 M 86.7 M 48.1 M 22.1 M 15.9 M

Cash and Cash Equivalents

92.9 M 102 M 299 M 553 M 113 M 42 M 56.7 M 25 M 55.1 M 55.7 M 40.5 M 16.5 M 9.75 M

Book Value

161 M 58.6 M 237 M 519 M 38.6 M 24 M 67 M 35.9 M 102 M 80.1 M 40.1 M 15.6 M 9.64 M

Total Shareholders Equity

161 M 58.6 M 237 M 519 M 38.6 M 24 M 67 M 35.9 M 102 M 80.1 M 40.1 M 15.6 M 9.62 M

All numbers in USD currency

Quarterly Balance Sheet TG Therapeutics

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

103 M 101 M 100 M 98.9 M 97.7 M 96.5 M 71.1 M 71.1 M 68.9 M 67.2 M 66.8 M 30.6 M 30.4 M 30.1 M 7.72 M 7.72 M 7.72 M 7.72 M 29 M 29 M 29 M 29 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

224 M 213 M 169 M 166 M 180 M 170 M 135 M 117 M 123 M 133 M 142 M 98.2 M 98.3 M 103 M 106 M 106 M 106 M 106 M 124 M 124 M 124 M 124 M 59.6 M 59.6 M 59.6 M 59.6 M 30.4 M 30.4 M 30.4 M 30.4 M 18.9 M 18.9 M 18.9 M 18.9 M 11.9 M 11.9 M 11.9 M 11.9 M 6.65 M 6.65 M 6.65 M 6.65 M 8.06 M 8.06 M 8.06 M 8.06 M 6.52 M 6.52 M 6.52 M 6.52 M 4.9 M 6.27 M 6.27 M 6.27 M

Deferred Revenue

3.37 M 3.37 M 152 K 6.9 M - - 152 K - - - - - - - - - - - - - - - 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K 152 K - - - -

Retained Earnings

-1.56 B -1.53 B -1.55 B -1.5 B -1.61 B -1.57 B -1.53 B -1.47 B -1.44 B -1.4 B -1.33 B -1.24 B -1.15 B -1.07 B -981 M -981 M -981 M -981 M -701 M -701 M -701 M -701 M -528 M -528 M 528 M -528 M -355 M -355 M -355 M -355 M -236 M -236 M -236 M -236 M -158 M -158 M -158 M -158 M -95.2 M -95.2 M -95.2 M -95.2 M -39.4 M -39.4 M -39.4 M - - - - - - - - -

Total Assets

401 M 373 M 330 M 331 M 221 M 197 M 194 M 218 M 252 M 303 M 380 M 410 M 481 M 549 M 626 M 626 M 626 M 626 M 163 M 163 M 163 M 163 M 83.6 M 83.6 M 83.6 M 83.6 M 97.4 M 97.4 M 97.4 M 97.4 M 54.8 M 54.8 M 54.8 M 54.8 M 113 M 113 M 113 M 113 M 86.7 M 86.7 M 86.7 M 86.7 M 48.1 M 48.1 M 48.1 M 48.1 M 22.1 M 22.1 M 22.1 M 22.1 M 14.5 M 15.9 M 15.9 M 15.9 M

Cash and Cash Equivalents

82.9 M 75.5 M 92.9 M 151 M 97 M 61.5 M 102 M 110 M 147 M 186 M 299 M 327 M 402 M 472 M 555 M 553 M 553 M 553 M 113 M 113 M 113 M 113 M 42 M 42 M 42 M 42 M 56.7 M 56.7 M 56.7 M 56.7 M 25 M 25 M 25 M 25 M 55.1 M 55.1 M 55.1 M 55.1 M 55.7 M 55.7 M 55.7 M 55.7 M 40.5 M 40.5 M 40.5 M 40.5 M 16.5 M 16.5 M 16.5 M 16.5 M 9.75 M 9.75 M 9.75 M 9.75 M

Book Value

178 M 160 M 161 M 165 M 40.5 M 27.4 M 58.6 M 100 M 129 M 170 M 237 M 312 M 383 M 445 M 519 M 519 M 519 M 519 M 38.6 M 38.6 M 38.6 M 38.6 M 24 M 24 M 24 M 24 M 67 M 67 M 67 M 67 M 35.9 M 35.9 M 35.9 M 35.9 M 102 M 102 M 102 M 102 M 80.1 M 80.1 M 80.1 M 80.1 M 40.1 M 40.1 M 40.1 M 40.1 M 15.6 M 15.6 M 15.6 M 15.6 M 9.64 M 9.64 M 9.64 M 9.64 M

Total Shareholders Equity

178 M 160 M 161 M 165 M 40.5 M 27.4 M 58.6 M 100 M 129 M 170 M 237 M 312 M 383 M 445 M 519 M 519 M 519 M 519 M 38.6 M 38.6 M 38.6 M 38.6 M 24 M 24 M 24 M 24 M 67 M 67 M 67 M 67 M 35.9 M 35.9 M 35.9 M 35.9 M 102 M 102 M 102 M 102 M 80.1 M 80.1 M 80.1 M 80.1 M 40.1 M 40.1 M 40.1 M 40.1 M 15.6 M 9.37 M 11 M 11.7 M 9.62 M 9.62 M 9.62 M 9.62 M

All numbers in USD currency